Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms
Hiroki Kabata, Kazuyo Moro, Shigeo Koyasu
Immunological Reviews (2018) Vol. 286, Iss. 1, pp. 37-52
Closed Access | Times Cited: 234

Showing 1-25 of 234 citing articles:

Type 2 immunity in the skin and lungs
Cezmi A. Akdiş, Peter D. Arkwright, Marie‐Charlotte Brüggen, et al.
Allergy (2020) Vol. 75, Iss. 7, pp. 1582-1605
Open Access | Times Cited: 420
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, et al.
International Forum of Allergy & Rhinology (2023) Vol. 13, Iss. 4, pp. 293-859
Open Access | Times Cited: 231
Regulation of immune responses by tuft cells
Christoph Schneider, Claire E. O’Leary, Richard M. Locksley
Nature reviews. Immunology (2019) Vol. 19, Iss. 9, pp. 584-593
Open Access | Times Cited: 216
Paneth Cell-Derived Lysozyme Defines the Composition of Mucolytic Microbiota and the Inflammatory Tone of the Intestine
Shiyan Yu, Iyshwarya Balasubramanian, Daniel Laubitz, et al.
Immunity (2020) Vol. 53, Iss. 2, pp. 398-416.e8
Open Access | Times Cited: 173
Type 2 immunity in allergic diseases
İsmail Öğülür, Yasutaka Mitamura, Duygu Yazıcı, et al.
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 10
Group 2 Innate Lymphoid Cells in Airway Diseases
Atsushi Kato
CHEST Journal (2019) Vol. 156, Iss. 1, pp. 141-149
Open Access | Times Cited: 143
Steroid-Resistant Asthma and Neutrophils
Takeshi Nabe
Biological and Pharmaceutical Bulletin (2019) Vol. 43, Iss. 1, pp. 31-35
Open Access | Times Cited: 97
Anti-TSLP antibodies: Targeting a master regulator of type 2 immune responses
Saeko Nakajima, Hiroki Kabata, Kenji Kabashima, et al.
Allergology International (2020) Vol. 69, Iss. 2, pp. 197-203
Open Access | Times Cited: 82
Recent advances in understanding the role of IL-4 signaling
Achsah Keegan, Warren J. Leonard, Jinfang Zhu
Faculty Reviews (2021) Vol. 10
Open Access | Times Cited: 75
The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases
Haocheng Zheng, Yi Zhang, Jiachuang Pan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 66
The Role of Crosstalk of Immune Cells in Pathogenesis of Chronic Spontaneous Urticaria
Bingjing Zhou, Jie Li, Runqiu Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis
Tanawin Nopsopon, Grace Lassiter, Ming‐Li Chen, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 3, pp. 747-755
Open Access | Times Cited: 42
Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity
Yingjiao Cao, Yu Li, Xiang-Yang Wang, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 320-335.e9
Open Access | Times Cited: 36
Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives
Yilu Zhou, Zhendong Xu, Zhiqiang Liu
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Blocking CD226 regulates type 2 innate lymphoid cell effector function and alleviates airway hyperreactivity
Yoshihiro Sakano, Kei Sakano, Benjamin P. Hurrell, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 153, Iss. 5, pp. 1406-1422.e6
Closed Access | Times Cited: 15
The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma
Kazuyuki Nakagome, Makoto Nagata
Biomolecules (2024) Vol. 14, Iss. 5, pp. 546-546
Open Access | Times Cited: 15
Physiological and immunological barriers in the lung
Takahiro Kageyama, Takashi Ito, Shigeru Tanaka, et al.
Seminars in Immunopathology (2024) Vol. 45, Iss. 4-6, pp. 533-547
Open Access | Times Cited: 12
TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation
Pauline Schmitt, Anais Dufros Duval, M. Camus, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 6
Open Access | Times Cited: 9
Maternal asthma imprints fetal lung ILC2s via glucocorticoid signaling leading to worsened allergic airway inflammation in murine adult offspring
T. Takao, Ako Matsui, Chie Kikutake, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell
Simone E. M. Olsthoorn, Anneloes van Krimpen, Rudi W. Hendriks, et al.
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 1
Respiratory Barrier as a Safeguard and Regulator of Defense Against Influenza A Virus and Streptococcus pneumoniae
Kim S. LeMessurier, Meenakshi Tiwary, Nicholas Morin, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 66
Basophils and their effector molecules in allergic disorders
Kensuke Miyake, Sho Shibata, Soichiro Yoshikawa, et al.
Allergy (2020) Vol. 76, Iss. 6, pp. 1693-1706
Open Access | Times Cited: 60
The use of biologics for immune modulation in allergic disease
Willem van de Veen, Mübeccel Akdiş
Journal of Clinical Investigation (2019) Vol. 129, Iss. 4, pp. 1452-1462
Open Access | Times Cited: 58
Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s
Marek Wagner, Kafi N. Ealey, Hiroe Tetsu, et al.
Cell Reports (2020) Vol. 30, Iss. 8, pp. 2743-2757.e5
Open Access | Times Cited: 56
Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies
Corrado Pelaia, Alessandro Vatrella, Luca Gallelli, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 1275-1284
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top